Enhancing Chemotherapy Capabilities in Rural Hospitals: Implementation of a Telechemotherapy Model (QReCS) in North Queensland, Australia.
Sabe Sabesan, Clare Senko, Andrew Schmidt, Abhishek Joshi, Ritwik Pandey, Corinne A Ryan, Megan Lyle, Natalie Rainey, Suresh Varma, Zulfiquer Otty, Zia Ansari, Kerrie Vaughan, Venkat Vangaveti, Jason Black, Amy Brown
Author Information
Sabe Sabesan: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Clare Senko: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Andrew Schmidt: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Abhishek Joshi: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Ritwik Pandey: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Corinne A Ryan: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Megan Lyle: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Natalie Rainey: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Suresh Varma: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Zulfiquer Otty: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Zia Ansari: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Kerrie Vaughan: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Venkat Vangaveti: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Jason Black: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
Amy Brown: Townsville Cancer Centre; Liz Plummer Cancer Care Centre, Cairns; Mackay Base Hospital; and James Cook University, Queensland, Australia.
INTRODUCTION: The Queensland Remote Chemotherapy Supervision (QReCS) model enables rural nurses to administer chemotherapy in smaller rural towns under supervision by health professionals from larger centers using telehealth. Its implementation began in North Queensland, Australia (population, 650,000), in 2014 between two regional cancer centers (Townsville and Cairns as primary sites) and six rural sites (125 to 1,000 kilometers from primary sites). Our study examined the implementation processes, feasibility, and safety of this model. METHODS: Details of implementation and patients' clinical details for the period of 2014 to 2016 for descriptive analysis were extracted from telechemotherapy project notes and oncology information systems of North Queensland, respectively. RESULTS: After a successful pilot study in Townsville Cancer Centre, statewide rural and cancer networks of Queensland Health, in collaboration with clinicians and managers across the state of Queensland, developed the QReCS model and a guide for operationalizing it. QReCS was implemented at six sites from 2014 to 2016. Main enablers across North Queensland included collaboration among clinicians and managers, availability of common electronic medical records, funding from Queensland Health, and installation of telehealth infrastructure by statewide telehealth services. Main barriers included turnover of senior management and nursing staff at two rural towns. Sixty-two patients received 327 cycles of low- to medium-risk chemotherapy agents. Rates of treatment delays, adverse events, and hospital admissions were similar to those in face-to-face care. CONCLUSION: Implementation of the QReCS model across a large geographic region is feasible with acceptable safety profiles. Leadership by and collaboration among clinicians and managers, adequacy of resources and common governance are key enablers.
